Analyst Rating In Review: Bristol-Myers Squibb Sold Off 3.8% Since Downgraded 7 Days Ago (BMY)

Berenberg downgraded Bristol-Myers Squibb (NYSE:BMY) from Buy to Hold a week ago. The shares closed at $58.68, or 3.8% under the $60.97 price of one week ago.Bristol-Myers Squibb (NYSE:BMY)...